Biofrontera Inc. Equity Securities, FV-NI, Gain (Loss)
Biofrontera Inc. (BFRI) reported Equity Securities, FV-NI, Gain (Loss) of -$14.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2025-03-20
- Biofrontera Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2024-06-30 was -$14.00K.
- Biofrontera Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2024-03-31 was $101.00K.
- Biofrontera Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2023-12-31 was -$1.21M.
- Biofrontera Inc. equity securities, fv-ni, gain (loss) for the quarter ending 2023-09-30 was -$1.87M.
- Biofrontera Inc. equity securities, fv-ni, gain (loss) for fiscal 2024 was -$14.00K.
- Biofrontera Inc. equity securities, fv-ni, gain (loss) for fiscal 2023 was -$7.42M.
- Biofrontera Inc. equity securities, fv-ni, gain (loss) for fiscal 2022 was -$1.75M.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 9 month | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$14.00K 10-K · filed 2025-03-20 | |||
| 2024-06-30 | -$14.00K 10-Q · filed 2024-08-14 | $87.00K 10-Q · filed 2024-08-14 | -$1.12M derived: sum of 3 quarters · filed 2025-03-20 | -$2.99M derived: sum of 4 quarters · filed 2025-03-20 |
| 2024-03-31 | $101.00K 10-Q · filed 2024-05-15 | -$1.10M derived: sum of 2 quarters · filed 2025-03-20 | -$2.97M derived: sum of 3 quarters · filed 2025-03-20 | -$4.38M derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-12-31 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$3.07M derived: sum of 2 quarters · filed 2025-03-20 | -$4.48M derived: sum of 3 quarters · filed 2025-03-20 | -$7.42M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$1.87M 10-Q · filed 2023-11-09 | -$3.27M derived: sum of 2 quarters · filed 2024-08-14 | -$6.21M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$1.41M 10-Q · filed 2024-08-14 | -$4.35M 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$2.94M 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$1.75M 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |